Menu
Medicines
GOCOVRI™ (amantadine) extended release capsules
GOCOVRI™ (amantadine) extended release capsules is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without dopaminergic medications.

For full prescribing information, visit www.GOCOVRI.com.

Partnered Product
namzaric
NAMZARIC® (memantine HCl and donepezil HCl) extended-release capsules
NAMZARIC is marketed by Allergan plc pursuant to an exclusive license agreement between Forest Laboratories Holdings Limited, an indirect wholly owned subsidiary of Allergan plc and Adamas Pharmaceuticals, Inc.

Visit www.NAMZARIC.com for more details.